KEISHA ALLEN: Open Payments
NPI 1871843573 · MCDOWELL, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$310 in 16 payments from 8 companies in 2025. Trend: 2023 $210 · 2024 $301 · 2025 $310
Food & beverage: $310
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $81 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $41 |
| PFIZER INC. | 2 | $33 |
| Lundbeck LLC | 1 | $22 |
| Valinor Pharma, LLC | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: AIRSUPRA, CAPLYTA, Ozempic, JOURNAVX, Wegovy, REXULTI, MOVANTIK, VYNDAMAX.
Industry payments across KY — which companies pay providers there.
